Showing results (521-530 of 2,462) with videos related to
Sort By:
Pageof 247
Journal of Gastrointestinal Oncology|September 18, 2023
The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective studyJian Xiong, Yanyan Zhou, Kai Tan, et al.Journal of Gastrointestinal Oncology|January 10, 2024
Immunotherapy before liver transplant in unresectable hepatocellular carcinoma: a case reportHyejee Ohm, Raida Khwaja, Hatim KarachiwalaJournal of Gastrointestinal Oncology|January 10, 2024
Risk factors for remnant gastric cancer after distal gastrectomy for gastric cancer: a retrospective database reviewShinya Sakamoto, Ikuo Wada, Kiyohiko Omichi, et al.Journal of Gastrointestinal Oncology|January 10, 2024
A narrative review of the evolving landscape of the management of metastatic gastric cancer: the role of targeted therapiesGlenda M Delgado-Ramos, Jack Fitzsimons, Asha DhanarajanJournal of Gastrointestinal Oncology|January 10, 2024
Development and validation of a nomogram to predict pathological complete response in patients with locally advanced gastric adenocarcinoma treated with neoadjuvant chemotherapy in combination with PD-1 antibodiesLiang Li, Guanglong Chen, Emerson Y Chen, et al.Journal of Gastrointestinal Oncology|January 10, 2024
Camrelizumab and apatinib combined with chemotherapy in perioperative effective therapy for advanced gastric carcinoma with peritoneal metastasis: a case reportSong Liang, Xinan Fang, Pin Jiang, et al.Journal of Gastrointestinal Oncology|January 10, 2024
Significant response from fruquintinib plus anti-PD-1 immunotherapy for microsatellite stable metastatic colorectal cancer with liver and lung metastasis in the third line: case reportLina He, Xiaojiao Cheng, Cong Zhou, et al.Journal of Gastrointestinal Oncology|January 10, 2024
Prognostic value of the ratio of pretreatment carcinoembryonic antigen to tumor volume in rectal cancerZhiming Zeng, Decai Ma, Pan Zhu, et al.Journal of Gastrointestinal Oncology|March 14, 2024
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case reportJames Yu, Trenton A Avriett, Christopher M Ray, et al.Journal of Gastrointestinal Oncology|March 14, 2024
Regorafenib combined with a PD-1 inhibitor in the second-line setting for unresectable hepatocellular carcinoma in real-world practiceHuaqiang Bi, Jun Pei, Kuansheng Ma, et al.Pageof 247